M
Metech International Ltd
SGX:V3M
Metech International Ltd
SGX:V3M
Price:
0.024
SGD
-36.84%
Market Closed
Market Cap:
S$4.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Metech International Ltd
SGX:V3M
|
SG |
|
Y Ventures Group Ltd
SGX:1F1
|
SG |
|
OptiBiotix Health PLC
LSE:OPTI
|
UK |
|
Altarea SCA
OTC:ATRRF
|
FR |
|
A
|
Acarix AB
STO:ACARIX
|
SE |
|
Inversiones Doalca SOCIMI SA
MAD:YDOA
|
ES |
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
US |
|
Singapore Land Group Ltd
SGX:U06
|
SG |
|
Patterson-UTI Energy Inc
NASDAQ:PTEN
|
US |
|
N
|
New Tech Venture SA
WSE:NTV
|
PL |
|
Tokyu Corp
TSE:9005
|
JP |
|
Future Enterprises Ltd
NSE:FEL
|
IN |
|
MGP Ingredients Inc
NASDAQ:MGPI
|
US |
|
Samsung Life Insurance Co Ltd
KRX:032830
|
KR |
|
Bridgestone Corp
TSE:5108
|
JP |
Balance Sheet
Balance Sheet Decomposition
Metech International Ltd
Metech International Ltd
Balance Sheet Decomposition is not available for
Metech International Ltd
Metech International Ltd
Balance Sheet
Metech International Ltd
Metech International Ltd
Currency: SGD
| Dec-2023 | Dec-2024 | ||
|---|---|---|---|
| Assets | |||
| Cash & Cash Equivalents |
0
|
1
|
|
| Cash Equivalents |
0
|
1
|
|
| Total Receivables |
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
|
| Other Receivables |
0
|
0
|
|
| Inventory |
0
|
0
|
|
| Total Current Assets |
0
|
2
|
|
| PP&E Net |
1
|
0
|
|
| Long-Term Investments |
0
|
0
|
|
| Total Assets |
1
N/A
|
2
+57%
|
|
| Liabilities | |||
| Accounts Payable |
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
|
| Total Current Liabilities |
1
|
4
|
|
| Long-Term Debt |
0
|
0
|
|
| Minority Interest |
1
|
1
|
|
| Other Liabilities |
0
|
0
|
|
| Total Liabilities |
0
N/A
|
3
+1 953%
|
|
| Equity | |||
| Common Stock |
189
|
190
|
|
| Retained Earnings |
188
|
190
|
|
| Total Equity |
1
N/A
|
1
N/A
|
|
| Total Liabilities & Equity |
1
N/A
|
2
+57%
|
|
| Shares Outstanding | |||
| Common Shares Outstanding |
152
|
170
|
|
Switch to:
Switch to:
See Also
Discover More
